EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor

Term ID

CHEBI:139339

Synonyms

(3,4-dihydroxyphenethylamine)beta-mono-oxygenase inhibitor
(3,4-dihydroxyphenethylamine)beta-mono-oxygenase inhibitors
3,4-dihydroxyphenethylamine beta-oxidase inhibitor
3,4-dihydroxyphenethylamine beta-oxidase inhibitors
3,4-dihydroxyphenethylamine,ascorbate:oxygen oxidoreductase (beta-hydroxylating) inhibitor
3,4-dihydroxyphenethylamine,ascorbate:oxygen oxidoreductase (beta-hydroxylating) inhibitors
4-(2-aminoethyl)pyrocatechol beta-oxidase inhibitor
4-(2-aminoethyl)pyrocatechol beta-oxidase inhibitors
DbetaH inhibitor
DbetaH inhibitors
dopa beta-hydroxylase inhibitor
dopa beta-hydroxylase inhibitors
dopamine beta-hydroxylase inhibitor
dopamine beta-hydroxylase inhibitors
dopamine beta-monooxygenase (EC 1.14.17.1) inhibitor
dopamine beta-monooxygenase (EC 1.14.17.1) inhibitors
dopamine beta-monooxygenase inhibitor
dopamine beta-monooxygenase inhibitors
dopamine beta-oxidase inhibitor
dopamine beta-oxidase inhibitors
dopamine hydroxylase inhibitor
dopamine hydroxylase inhibitors
dopamine-B-hydroxylase inhibitor
dopamine-B-hydroxylase inhibitors
EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitors
EC 1.14.17.1 inhibitor
EC 1.14.17.1 inhibitors
MDBH (membrane-associated dopamine beta-monooxygenase) inhibitor
MDBH (membrane-associated dopamine beta-monooxygenase) inhibitors
oxygenase, dopamine beta-mono-phenylamine beta-hydroxylase inhibitor
oxygenase, dopamine beta-mono-phenylamine beta-hydroxylase inhibitors
SDBH (soluble dopamine beta-monooxygenase) inhibitor
SDBH (soluble dopamine beta-monooxygenase) inhibitors

Definition

An EC 1.14.17.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen and with reduced ascorbate as one donor, and incorporation of one atom of oxygen) inhibitor that interferes with the action of dopamine monooxygenase (EC 1.14.17.1).

References

Wikipedia:Dopamine_beta-hydroxylase

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 1.14.17.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen and with reduced ascorbate as one donor, and incorporation of one atom of oxygen) inhibitor

EC 1.14.17.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen and with reduced ascorbate as one donor, and incorporation of one atom of oxygen) inhibitor Show first 5 Terms
inverse has_role: 4-hydroxybenzaldehyde nepicastat

4-hydroxybenzaldehyde nepicastat Show first 5 Terms

Phenotype

Phenotype resulting from EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor

Phenotype where environments contain EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor

Phenotype modified by environments containing EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor

Human Disease Model